Tag: shots

Categories
Health

Covid-19 omicron pictures out there, however their effectiveness is unclear

Covid-19 omicron shots available, but their effectiveness is unclear

The US this week approved the first major revision of Covid-19 vaccines in a bid to stem an expected spate of infections and hospitalizations this fall.

However, it is unclear how much protection the new booster shots will offer. The Food and Drug Administration and the Centers for Disease Control and Prevention have cleared the footage without data from clinical trials testing the newly formulated doses in humans.

The new boosters, approved for people 12 and older, target the highly contagious and immune-avoidable subvariant omicron BA.5, which sparked a surge in breakthrough infections over the summer. The shots also targeted the original strain of the virus, which first emerged in Wuhan, China, in 2019.

The country’s top health authorities acted urgently this summer to ensure the new boosters are rolled out in time for the fall. They are concerned that the declining effectiveness of legacy vaccines creates an opportunity for omicron to trigger another wave of hospitalizations this winter as people spend more time indoors, where the airborne virus spreads more easily.

According to CDC epidemiologist Heather Scobie, deaths and hospitalizations among the elderly, the most commonly vaccinated age group in America, have risen since April as Omicron continues to mutate into more transmissible subvariants that evade the protection of the original vaccines.

dr Peter Marks, who heads the FDA’s office that reviews vaccines, said the new boosters aim to restore the high level of protection vaccines showed in early 2021. However, Marks acknowledged that federal government experts just don’t know yet whether the boosters will meet the high bar that these doses set.

“We don’t yet know exactly if we’ll reach the same level, but that’s the goal here. And we think the evidence we’ve seen suggests that,” Marks told reporters during a news conference following the FDA approval Wednesday.

The FDA will be monitoring to see if the boosters are meeting that goal, Marks said. When Pfizer and Moderna’s syringes were approved in December 2020, they offered more than 90 percent protection in preventing Covid.

Marks told reporters it will likely be at least a few more months before human data on the BA.5 boosters is available to the public. But he said the FDA used essentially the same process to authorize the new boosters it’s relied on for years to switch virus strains in flu shots.

“We’re pretty confident that what we have is very similar to the situation that we’ve done in the past with influenza mutations where we’re not conducting clinical trials for them in the United States,” Marks said. “We know from how the vaccine works and from the data we have that we can predict how well the vaccine will work.”

The new boosters could prevent 2.4 million infections, 137,000 hospitalizations and 9,700 deaths if no new variant emerges, according to a forecast by a team of scientists predicting the course of the pandemic, called the Covid-19 Scenario Modeling Hub.

However, according to the scientists, this forecast is based on optimistic assumptions about the coverage and effectiveness of boosters. The model assumes that vaccines will prove 80% effective in preventing disease and the public will largely embrace the new boosters. There is no efficacy data on the new shots and it is unclear how strong the public demand for them will be.

The CDC estimates that an early fall immunization campaign with booster shots could save the United States between $63 billion and $109 billion in medical costs by preventing hospitalizations and ICU admissions.

Pfizer and Moderna originally developed new boosters to target the first version of Omicron, BA.1, which caused the massive wave of infections and hospitalizations last winter. But keeping up with the rapid evolution of the virus has proven to be a challenge.

By the time the country’s top health leaders began providing new boosters in earnest in April, more transmissible subvariants had already pushed omicron BA.1 out of circulation. In June, the FDA urged vaccine makers to shift gears and target Omicron BA.5 after it rose to dominance.

That decision didn’t leave Pfizer and Moderna enough time to complete human clinical trials of the new boosters before a fall launch of the vaccine.

As a result, the FDA and CDC rely on human data from the clinical trials of the BA.1 syringes to understand how the BA.5 boosters might work. They also relied on data from studies testing the BA.5 boosters in mice.

The CDC’s Independent Advisory Committee supported the shooting Thursday in an overwhelming vote.

However, some members of the panel also had concerns about the lack of human data.

“I’m really struggling with a vaccine that doesn’t have clinical data that’s reported for people, for those who would actually get the vaccine,” said Dr. Oliver Brooks, a committee member and chief medical officer at Watts HealthCare Corp. in Los Engel.

dr Pablo Sanchez, the only member of the CDC committee who voted against the injections, called the decision to recommend the new boosters without human data premature.

“There’s already a lot of hesitation with vaccines — we need the human data,” said Sanchez, a professor of pediatrics at Ohio State University.

dr Doran Fink, deputy chief of the FDA’s Division of Vaccine Review, told the hesitant committee members that the new booster shots use the exact same manufacturing process as the old vaccines and contain the same total amount of mRNA, the code that instructs human cells to produce the proteins that evoke an immune response to fight off Covid.

Fink said the BA.1 and the BA.5 recordings are similar enough to use data from the BA.1 human trials to get a good idea of ​​how the new BA.5 boosters work will work.

Pfizer and Moderna presented data at the CDC meeting showing that the BA.1 vaccines elicited a stronger immune response in humans than the old vaccines. The mouse studies by both companies on the BA.5 syringes also showed a stronger immune response.

CDC Director Dr. Rochelle Walensky said last week that a longer wait for human data from the BA.5 shots could mean the boosters are out of date by the time a new variant emerges.

“It’s always about too slow versus too fast,” Walensky told Conversations on Health Care in a radio interview. “One of the challenges is when we wait for that data to show up in human data… we’re going to be using what I think might be an outdated vaccine.”

Moderna completed recruitment for its clinical trials last week and expects results by the end of the year. Pfizer’s clinical trials are ongoing, although the company hasn’t given a timeline for when it will have data.

Brooks questioned why the FDA chose a BA.5 vaccine when clinical data is available for the BA.1 vaccines that vaccine manufacturers originally developed. Canada and the UK have approved new booster shots targeting omicron BA.1

Fink said the US approved BA.5 based on advice from the FDA’s independent committee, data from South Africa indicating that natural infection by the subvariant provides broader protection than infection by BA.1, and the fact that BA.5 is dominant.

Although committee members were somewhat reluctant to proceed without the human data, they agreed that the new boosters should have a similar safety profile to the old vaccines, as they use the same platform. The Covid vaccines have been given to millions of people in the US with mostly mild side effects.

According to the FDA, the most common side effects from the human trials of BA.1 syringes were pain, redness, swelling at the injection site, fatigue, headache, muscle pain, joint pain, chills, nausea, vomiting, and fever.

dr Sara Oliver, a CDC official, told the committee that the risk of myocarditis, an inflammation of the heart muscle, after a BA.5 booster is unknown. However, health authorities believe it will be similar to the risk seen with the old vaccines.

The Pfizer and Moderna vaccines have been associated with an increased risk of myocarditis in young men and adolescent boys, mainly after the second dose. However, according to the CDC, the risk of myocarditis is higher from Covid infection than from vaccination.

dr Grace Lee, the chair of the CDC committee, tried to reassure the public that there is a robust monitoring system to monitor safety and that the panel will meet again if new concerns arise.

“I just want to make sure members of the public know we’re continuing to monitor closely,” Lee said. “We have systems and teams that continue to monitor and meet.”

Categories
Health

CDC clears reformulated Covid pictures concentrating on omicron in time for varsity

Millions of Americans could be eligible for a new Covid refresher

Justin Sullivan | Getty Images

The Centers for Disease Control and Prevention have released reformulated Covid shots targeting the latest Omicron subvariants for the fall, allowing many people to get an extra boost in days.

The agency’s independent committee on vaccines voted 13-1 in favor of the shots on Thursday after reviewing the available safety and efficacy data in a nearly seven-hour session. CDC Director Dr. Rochelle Walensky approved the injections a few hours later, clearing the way for pharmacies to administer the injections soon.

Pfizer’s Omicron boosters were approved for ages 12+, while Moderna’s updated shots were approved for ages 18+. The eligible age groups can receive the boosters no earlier than two months after the completion of their primary series or their last booster with the old vaccinations.

Walensky said her decision followed “a thorough scientific evaluation and sound scientific discussion.”

“If you are eligible, there is no bad time to get your Covid-19 booster and I strongly encourage you to get it,” she said in a statement.

Pfizer plans to ask the Food and Drug Administration to also approve the new boosters for children ages 5 to 11 in early October, company executives told the committee Thursday.

The original vaccines are no longer used as a booster dose in people aged 12 and over as the reformulated vaccines are now online.

Public health officials expect another wave of Covid infections this fall as immunity to the legacy vaccines wanes, more contagious omicron subvariants spread and people spend more time indoors as the weather turns colder and families close gather for the holidays.

The CDC and FDA hope the new boosters will provide more durable protection against infection, mild illness, and serious illness. The reformulated shots target omicron BA.5, the dominant variant of Covid, as well as the strain that emerged in China more than two years ago.

The US has so far secured 171 million doses of the new boosters from Pfizer and Moderna. More than 200 million people are entitled to the recordings, according to the CDC. dr Sara Oliver, a CDC official, told the committee Thursday there should be enough vaccine supplies to meet demand this fall.

No omicron BA.5 human data

There is no human trial data on the new BA.5 boosters, so it is unclear how they will perform in the real world. The CDC and FDA used human clinical trial data for vaccinations against the original version of Omicron, BA.1, which elicited a stronger immune response than the old vaccines.

Pfizer and Moderna originally developed Omicron boosters for BA.1, but the FDA told the companies to change gears in June and develop BA.5 shots instead after the subvariant became dominant. The decision to focus on BA.5 did not leave enough time to wait for data from human trials before a vaccine launch in the fall.

The lack of human data for the BA.5 vaccines has caused some controversy, but Dr. Peter Marks, a senior FDA official, said the agency has followed the same process it has used for years to change strains for flu vaccines. Marks said Wednesday flu vaccine strains are being changed even without human clinical data.

dr Pablo Sanchez, the only committee member who voted against the injections, called the recommendation premature and said the US should have waited for human data before proceeding with the boosters.

“There’s already a lot of hesitation with vaccines — we need the human data,” said Sanchez, a professor of pediatrics at Ohio State University. But Sanchez said he believes the new boosters are safe and he will likely receive one himself.

CNBC Health & Science

Read CNBC’s latest global health coverage:

Board member Dr. Oliver Brooks, chief medical officer at Watts HealthCare Corporation in Los Angeles, questioned why the FDA chose a BA.5 vaccine when clinical data is available for the BA.1 vaccine that vaccine manufacturers are initially developing had. Brooks eventually voted for the shots.

But dr Sarah Long, also a committee member, said there was no reason to believe the BA.5 boosters will be inferior to the old vaccines as they also contain the original Covid strain and have the potential to increase hospitalizations and deaths along the way in the future to reduce autumn and winter. Long also voted in favour.

mouse studies

FDA and CDC officials have said that the omicron BA.1 and omicron BA.5 boosters are similar enough that the immune response data of the BA.1 vaccine should give a good indication of how the BA.5 vaccine will work. Omicron BA.1 and BA.5 are according to Dr. Jacqueline Miller, who works on vaccine development at Moderna, are closely related and share a difference of four mutations.

Moderna completed enrollment in clinical trials on the BA.5 shots last week and should have results by the end of the year, Miller told the CDC committee on Thursday. Pfizer’s clinical trial is also ongoing, although the company hasn’t said when it expects results.

Health authorities also reviewed data on the BA.5 shots from mouse studies. Moderna presented data showing that the BA.5 shots increased antibodies in mice more than four-fold compared to the old shots. The mice express the same cellular protein as humans, to which the virus attaches. Pfizer’s BA.5 booster increased antibodies in mice by 2.6-fold compared to the original vaccine.

security

According to the FDA, the most common side effects from the human trials of BA.1 injections were pain, redness, swelling at the injection site, fatigue, headache, muscle pain, joint pain, chills, nausea, vomiting, and fever.

Oliver, the CDC official, told the committee that health officials do not expect a difference in the safety profile of the BA.1 and BA.5 shots because the subvariants differ by only a few mutations.

However, Oliver noted that the risk of myocarditis following a BA.5 booster dose is unknown. Young men and adolescent boys are at increased risk of myocarditis after the second dose of Pfizer and Moderna, but the risk of myocarditis from Covid infection is higher, according to the CDC.

“We know that the risk of myocarditis is unknown, but expect a risk similar to that seen after the monovalent vaccines,” Oliver said. The monovalent vaccines are the old vaccines that have been given to millions of people in the US over the last two years.

Old vaccines are losing their effectiveness

The original vaccines, which were first approved in December 2020, no longer offer any meaningful protection against infection because the virus has mutated so much in the last two years. The shots were developed against the first strain to appear in China, so they are no longer tailored to attack the expanding Omicron subvariants.

Infections, hospitalizations and deaths have all fallen dramatically since last winter’s massive Omicron outbreak, but have leveled off at stubbornly high levels this summer. Omicron BA.5 is the most contagious and immune-avoidable variant to date, and breakthrough infections have become increasingly common as a result.

The effectiveness of the old vaccines against hospitalization also decreased after omicron BA.5 became dominant. A third dose was 77% effective at preventive hospitalization four months after receiving the shot, but protection dropped to as much as 34% at 120 days, according to CDC data. A fourth dose in people aged 50 and over was 56% effective in preventing hospitalization at four months.

Deaths and hospitalizations from Covid among people aged 65 and older have increased since April, according to Heather Scobie, a CDC epidemiologist who presented data during Thursday’s meeting. The number of deaths has increased, particularly among people aged 75 and over, Scobie said.

The CDC has shifted to a more focused public health response, with a focus on protecting the most vulnerable — the elderly, those with serious illnesses and those with weakened immune systems. Though there’s no data on the real-world effectiveness of the new boosters, the US is moving quickly to introduce them in hopes they’ll protect people this fall.

Categories
Health

‘Please get vaccinated now,’ Biden urges after FDA approves Pfizer Covid photographs

'Please get vaccinated now,' Biden urges after FDA approves Pfizer Covid shots

United States President Joe Biden speaks in the East Room of the White House in Washington, DC on Wednesday, August 18, 2021.

Pete Marovich | Bloomberg | Getty Images

President Joe Biden again urged more Americans to get vaccinated against Covid-19 on Monday, saying the majority of deaths and hospitalizations in the United States from the virus are unvaccinated.

“Those who have been waiting for full approval should take their chance now,” Biden said during a press conference at the White House hours after the Food and Drug Administration completed the full Covid vaccine from Pfizer and BioNTech for people aged 16 and over Had granted approval.

He said the US agency had evaluated “mountains” of clinical study data and determined “without question” that the Covid syringe was safe and highly effective.

“The overwhelming majority of people hospitalized with Covid-19, or almost all of those who have died of Covid-19, are not vaccinated, not vaccinated,” he told reporters. “If you are fully vaccinated – both vaccinations plus two weeks – your risk of developing serious Covid-19 is very, very small.”

“Please get vaccinated now,” added Biden.

According to the agency, FDA scientists evaluated “hundreds of thousands of pages” of vaccine data from 40,000 study participants before granting approval. The two-dose vaccine was found to be 91% effective in preventing Covid – slightly lower than the 95% effectiveness rate study data shown when the vaccine was approved late last year and before the Delta variant prevailed in the USA

So far, the mRNA vaccine, marketed as Comirnaty, has been on the US market under emergency approval granted by the FDA in December. Since then, more than 204 million Pfizer shots have been administered, according to the Centers for Disease Control and Prevention.

Biden’s latest plea comes because coronavirus cases are still safe nationwide, filled by the highly contagious Delta variant. The president said U.S. health officials are beginning to see signs that new cases may decline in some regions of the nation. Still, he said, cases are increasing overall, especially among the unvaccinated.

US officials believe vaccination is the best way to stave off rising cases. According to the Centers for Disease Control and Prevention, about 51% of the entire US population will be fully vaccinated against Covid as of Sunday.

The US approval is expected to spark a new wave of vaccine mandates from American companies and schools. Large companies have already told some or all of their employees that they need to get a full Covid vaccination this fall. Still, despite having legal authority to do so, health experts say some private companies and other institutions may be reluctant to request the shots before full approval.

Earlier in the day, New York City officials said they are now requiring all 148,000 public school teachers and employees to receive their Covid-19 vaccine shots this fall. They had previously said that employees could avoid the vaccines if they had regular weekly Covid tests.

During his speech, Biden urged other schools and companies to prescribe the vaccine.

“All over the world people want these vaccines here in America,” he said. “They’re free, convenient, and waiting for you. So today please go for yourself, for your loved ones, for your neighbors, for your country.”

– CNBC’s Rich Mendez and Bob Towey contributed to this report.

Categories
Health

US to Advise Booster Photographs for Most Individuals Eight Months After Vaccination

U.S. to Advise Boosters for Most Americans 8 Months After Vaccination

Before vaccinating health care workers, Dr. Orlowski, hospitals will need data on booster vaccination side effects so they know how to stagger vaccinations among their staff without affecting their ability to care for patients. “You can’t do the whole ICU at the same time,” she said, “because you don’t want everyone to have a fever and chills.”

In interviews on Tuesday, hospital officials and doctors generally supported calls for a booster vaccination. Unlike the vaccination campaign that started last winter, they said there will be enough doses this time around to make things run more smoothly.

Updated

Aug. 19, 2021, 8:59 p.m. ET

“I think we’re running out of second chances,” said Dr. Matthew Harris, the medical director of the coronavirus vaccination program at Northwell Health, New York’s largest hospital system. “What keeps me up at night is the inevitability of a variant that doesn’t respond to the vaccine. So if we have that head start, I fully support it.”

Dr. Danny Avula, Virginia’s vaccine coordinator, said his state has thousands of vaccine providers and can probably manage booster vaccinations without much change. “What caused so much of the urgency and frenzy of January through April was the delivery bottleneck,” he said. “I think it will be a completely different rollout for boosters than the first time it was recorded.”

The booster strategy has been discussed for several weeks, but a consensus on how to proceed was only reached in meetings this weekend. Officials said senior health officials all backed it, including surgeon general Dr. Vivek H. Murthy and the heads of the National Institutes of Health, the Food and Drug Administration, and the Centers for Disease Control and Prevention.

The government has more than 100 million cans in stock that could be used for boosters, plus dozens more in freezers at pharmacies and other locations. The government has bought even more supplies slated for this fall, and officials say they are not worried about running out.

Federal health officials were particularly concerned about data from Israel suggesting the Pfizer BioNTech vaccine’s protection against serious illness has fallen significantly in older people who received their second vaccination in January or February.

Categories
Health

U.S. to require nursing houses workers get photographs or lose federal funding

U.S. to require nursing homes staff get shots or lose federal funding

President Joe Biden announced Wednesday that his government will require all nursing home workers to be vaccinated against Covid-19, the latest move to protect Americans if the Delta variant spreads.

“Today I announce a new step,” said Biden in a speech at the White House. “If you work in a nursing home and care for people on Medicare or Medicaid, you also need to get vaccinated.”

Biden’s remarks came after an administrative official confirmed to NBC News that the government will withhold federal funding from nursing homes that don’t fully vaccinate their employees.

The new policy, which would hold back funding for Medicare and Medicaid nursing homes that fail to comply, could go into effect as early as next month, the official said, although the timing is fluid. This would affect around 15,000 nursing homes, which employ more than 1.3 million people nationwide.

The move comes as the highly contagious Delta variant is causing a surge in new cases nationwide, and federal officials say they are starting to see signs of declining vaccine protection against mild and moderate illnesses.

According to data compiled by Centers for Medicare & Medicaid Services, roughly 60% of nursing home workers nationwide are vaccinated – much less than the 82.4% of residents who received the vaccinations. In some states, the percentage of nurses who have been vaccinated is even lower.

Some medical experts have asked the U.S. government to pressure nursing homes to vaccinate their staff, saying the unvaccinated staff put older residents at greater risk, who are more likely to become seriously ill or have something called a breakthrough infection.

“We have to go faster. So I’m taking vaccination measures where I can, ”Biden said in the speech.

The new rules for nursing homes are “all about keeping people safe and safe,” he said.

“This is no time to let our vigilance down. We just have to finish the job, with science, with facts and with confidence,” said the president.

Earlier in the day, federal health officials announced that they plan to provide booster shots to most Americans from the week of September 20th. They said it was “very clear” that immunity decreased after the first two doses, and with the dominance of the Delta variant, “we are gradually seeing signs of decreased protection against mild and moderate illnesses.”

“Based on our latest assessment, current protection against serious illness, hospitalization and death could decline in the coming months, especially for those at higher risk or who were vaccinated during the earlier stages of vaccination,” said the statement signed by CDC director Dr. Rochelle Walensky, Acting FDA Commissioner Dr. Janet Woodcock, White House Senior Medical Advisor Dr. Anthony Fauci, and other US health leaders.

Nursing home residents, health care providers, and the elderly – the first groups to be vaccinated in December and January – will be targeted, according to Dr. Francis Collins, director of the National Institutes of Health, likely prioritized to get extra vaccinations.

Categories
Health

Airways break up on whether or not to require workers to get Covid photographs

Airlines split on whether to require employees to get Covid shots

A Southwest Airlines jet lands at Midway International Airport in Chicago, Illinois on January 28, 2021.

Scott Olson | Getty Images

U.S. airlines are increasingly divided over whether their flight attendants, pilots and other employees should be vaccinated against Covid-19.

United Airlines and Hawaiian Airlines announced this month that their U.S. employees, a total of around 73,000 people, will need to be vaccinated against the virus. Alaska Airlines is considering a similar mandate for its 20,000 or so employees if the Food and Drug Administration grants full approval to one of the vaccines, a move expected next month.

Other airlines, including Delta Air Lines, American Airlines, Southwest Airlines, and JetBlue Airways, have repeatedly said that they are encouraging but do not require staff to be vaccinated. However, Delta Air Lines requires that new employees be vaccinated.

Pilot unions for these airlines say vaccines should remain voluntary for their members. Following announcements by United and Hawaiian, airline unions that do not require vaccines said pilots expressed concern about what would happen if their airlines followed suit.

Delta variant

The concerns highlight potential challenges carriers could face in also mandating vaccinations. The airlines are all struggling with the recent increase in Covid cases in the US, as the Delta variant prevails and weighs on the demand for air travel – just as the ailing industry began to gain a foothold again.

More than a dozen large US companies have prescribed Covid vaccines for some or all of their employees.

A mandate “could bring an airline into conflict with its unions,” said Ben Baldanza, former CEO of Spirit Airlines.

However, higher Covid cases could affect airline reliability if enough employees are sick, at a time when they are already few and far between.

“You don’t want to touch the third rail, but you want to make sure you have an operation,” said Robert Mann, an aviation consultant and former airline manager.

The latest announcements of vaccine mandates or their lack of vaccine mandates by the airlines have received criticism and praise from both sides on social media. Baldanza said he doesn’t think vaccine status will be a determining factor in booking flights.

Infections are increasing

At the same time, some unions argue that airlines could do more to boost vaccination rates, or urge pilots to use incentives such as extra vaccination time off, especially as the fast-spreading Delta variant is driving the new Covid-19 infections.

The Allied Pilots Association, which represents about 15,000 pilots at American Airlines on Thursday, told members that weekly cases of Covid-19 among pilots have hit an “all-time high,” rising to 36 in the first week of August, double that number as before three weeks earlier.

According to the union, five pilots were hospitalized for Covid-19 on August 12.

“It’s worth noting that none of these pilots have been vaccinated against the virus,” the union’s aero-medical group said.

About 60% of American Airlines pilots are vaccinated, according to a union announcement earlier this month. More than 90% of United pilots are vaccinated, the airline said. United previously offered flight attendants and pilots incentives to get vaccinated.

Encouraging, not demanding

Southwest Airlines reiterated to staff last week that it has not changed its stance on encouraging, but not requiring, staff to be vaccinated.

But Southwest Airlines Pilots Association president Casey Murray last week called on the company to discuss its vaccine plans and stated in a letter to the airline that its current policy is “obviously not set in stone”.

Murray told CNBC that some pilots have told the union that they are concerned about possible side effects from the gunshots, including long-term side effects that may take a while to show up and subsequent loss of paid sick leave or even their medical clearance issued to the Flying is required. The Senior Medical Advisor to the White House, Dr. Anthony Fauci said that “almost all” long-term vaccine side effects occur within the first two months of being vaccinated.

Meanwhile, Murray said the number of Covid cases among pilots is increasing but declined to provide numbers.

Corporate incentives

He said the company should establish guidelines and incentives that could include paying a federally mandated 48-hour wait for pilots to fly before they can fly after each dose of Pfizer or Moderna vaccine.

“Talking to the company will go a long way towards allaying those fears,” he said.

Murray noted in his letter that Southwest did not offer pilots incentives to vaccinate as Delta, American, and United did, such as extra time off or extra pay. Offering around $ 15 worth of points on an internal platform was “undoubtedly less effective than the real incentives negotiated by the other airlines with their unions,” he wrote to the company, according to a person familiar with the matter .

“Now that we are facing the escalation of the Delta variant crisis, this will prove significant,” he said.

Ed Bastian, Delta CEO, said last week a vaccine mandate would likely not increase vaccine rates, which he believes already account for about 75% of the company’s roughly 75,000 employees. He said five to ten percent of employees likely have a medical or religious exception for a vaccine.

Voluntary vaccinations

The Atlanta-based airline announced to the Air Line Pilots Association last week of its intention to keep vaccines voluntary, according to a union memo.

“We understand that Covid vaccinations have become an emotional issue,” said the pilots union. “Although an overwhelming majority of the pilot group chose the Covid vaccine, please don’t let this issue become a distraction on the flight deck.”

JetBlue CEO Robin Hayes said the New York airline is “reviewing” a vaccination mandate and debating with unions and employees, but the company is “right now” strongly encouraging employees to get vaccinated.

“I think it’s better that people get vaccinated because they want to get vaccinated,” Hayes said in an interview last week. “I think once the US government [fully] approved [the vaccines]”I think that will bring a huge increase in the number of people being vaccinated.” Pfizer and Moderna both received conditional approval to distribute their vaccines in an emergency in December, pending full approval by the Food and Drug Administration. Pfizer’s Covid vaccine is expected to receive full approval in a few weeks.

The union that represents the JetBlue pilots said: “We are certainly all ready for the COVID-19 pandemic to come to an end, but there shouldn’t be any rash decisions that affect our pilots and their ability to make private medical decisions with theirs Meeting healthcare providers, potentially compromising consultation, “the Air Line Pilots Association’s JetBlue chapter wrote to members last week.

Frontier Airlines said its employees who refuse to be vaccinated would instead have to test regularly for Covid. United, on the other hand, said employees will be fired if they refuse to get the syringes, although there are exceptions for medical or religious reasons.

More incentives

Mike Klemm, president of the International Association of Machinists District 141, which, among other things, represents around 28,000 customer and ramp service employees at United, estimates that around a third of them are rejecting the mandate.

“That 35% is much louder than the 65%,” he said, adding that while United asked for a lawsuit against the company, it was “in their legal right.”

United is offering a day off for vaccinated workers, but Klemm said it should offer more.

“If they increased the incentive, more people would be attracted to get the vaccine,” he said. “I understand what the company is trying to do, but they should have just given incentives … instead of intimidating people.”

United CEO Scott Kirby told CNN last week that most of the feedback he has received from employees on the move has been positive.

“It’s a highly explosive decision,” said aeronautical advisor Mann. “One way or another, you invite criticism.”

Categories
Health

CDC panel prepares to vote on Covid vaccine booster pictures for weak People

CDC panel prepares to vote on Covid vaccine booster shots for vulnerable Americans

Marilyn Lurie, who suffers from frontotemporal dementia, is being monitored in the back yard of her home by elderly caregiver Olga Lopez after receiving her first dose of COVID-19 vaccine as part of a mobile vaccination program on July 16, 2021 in Los Angeles, California.

Mario Tama | Getty Images News | Getty Images

A key advisory group from the Centers for Disease Control and Prevention is preparing to vote on Friday on distributing Covid-19 vaccine booster shots to Americans with compromised immune systems.

The CDC’s Advisory Committee on Immunization Practices is due to meet on Friday to consider Covid booster vaccinations for such people, including cancer and HIV patients. On Thursday, the CDC updated their website to indicate that a vote is scheduled for the meeting on Friday around 1 p.m. ET.

The Food and Drug Administration is expected to approve a third Covid vaccination for immunocompromised populations on Thursday, a highly anticipated move designed to protect some of the most vulnerable Americans from the highly contagious Delta variant.

However, the FDA’s OK is not the final go-ahead. The CDC Advisory Committee must then make a recommendation on how to distribute the booster shots. If the CDC accepts the advisory group’s recommendation as expected, third shots could begin immediately.

Immunocompromised populations would be the first group in the US to receive a booster vaccination. Federal health officials are not currently recommending additional doses for the general public.

People with compromised immune systems make up only about 2.7% of the adult US population. Still, they account for around 44% of hospitalized breakthrough Covid cases, according to recent data from the CDC group. A breakthrough case is infection in a fully vaccinated person.

The Senior Medical Advisor to the White House, Dr. Anthony Fauci said last week that new data suggests that immunocompromised people are not generating an adequate immune response after receiving two doses of a Covid vaccine.

CDC Director Dr. Rochelle Walensky, the FDA has worked closely with Pfizer and Moderna to give these vulnerable groups the opportunity to receive booster vaccinations.

“An extra dose could help increase protection for these people, which is especially important as the Delta variant is spreading,” she said during a Covid briefing at the White House. “This action is about ensuring that our most vulnerable, who may need an extra dose to improve their biological responses to the vaccines, are better protected from Covid-19.”

Categories
Health

Company provides closing OK to manage Covid vaccine booster pictures to susceptible Individuals

Agency gives final OK to administer Covid vaccine booster shots to vulnerable Americans

The Centers for Disease Control and Prevention on Friday gave final approval to give Covid-19 booster vaccinations to recipients of Pfizer and Moderna vaccines, hours after a key panel unanimously voted to allow third doses for immunocompromised Americans advocate.

“At a time when the Delta variant is on the rise, an extra dose of vaccine for some people with compromised immune systems could help prevent serious and potentially life-threatening COVID-19 cases in this population,” said CDC Director Dr . Rochelle Walensky in a statement.

The CDC’s decision and recommendation by the Advisory Committee on Immunization Practices followed the approval of the booster vaccination for immunocompromised patients by the Food and Drug Administration late Thursday. With the OK from both authorities, the booster doses could be given immediately.

“For the past almost a year and a half, I have cared for many patients with life-threatening and fatal diseases, and even post-vaccination,” who are immunocompromised, Dr. Camille Nelson Kotton, a transplant and infectious disease specialist at Massachusetts General Hospital, told the panel to strongly support boosters for those with weak immune systems. “They just suffer from a lack of good vaccination protection, we know that the vaccine is less effective in this population.”

Close-up of the Moderna vaccine at the Park County Health Department’s COVID-19 Vaccination Clinic for Seniors 80 and older on January 28, 2021 in Livingston, Montana.

William Campbell | Getty Images

FDA approval approved third doses of Pfizer and Moderna vaccines for “solid organ transplant recipients or those diagnosed with conditions believed to have equivalent levels of immunodeficiency.”

“New data suggests that some people with moderately to severely compromised immune systems do not always build the same level of immunity as people who are not immunocompromised,” said Walensky. “While immunocompromised people make up about 3% of the US adult population, they are particularly vulnerable to COVID-19 because they are at greater risk of developing serious, longer-lasting illnesses.”

Authorities have not released a booster vaccination to anyone else fully vaccinated or to recipients of Johnson & Johnson’s vaccine, which is manufactured in the Janssen vaccines division.

“There is currently no data to support the use of an additional dose of mRNA COVID-19 vaccine following a Janssen Covid-19 primary vaccine in immunocompromised people. The FDA and CDC are actively working to provide guidance on this matter,” said Dr. Neela. from CDC Goswami wrote to ACIP in her presentation.

The CDC recommended a third dose for at-risk Americans 28 days or more after completing the first two rounds of shooting. Booster doses are also recommended for cancer patients and HIV patients after data showed that immune responses after the first two doses did not provide adequate protection against Covid-19 and its variants in these patients.

The additional recordings were recommended for Pfizer recipients aged 12 and over and for Moderna recipients aged 18 and over. The panel said it will revisit the recordings for younger Moderna recipients after the FDA clears the recordings for children.

Immunocompromised patients make up approximately 2.7% of the US adult population and 44% of breakthrough hospital-treated infections that make someone infected even after being fully vaccinated.

Studies suggest that a third dose of the vaccine might help people whose immune systems do not respond as well to a first or second dose. Five small studies cited by the CDC showed that 11% to 80% of people with compromised immune systems had no detectable antibodies to Covid after two shots.

Among immunocompromised patients who had no detectable antibody response, 33 to 50% developed an antibody response after receiving an additional dose, according to the CDC.

Patients at risk are also more likely to experience persistent Covid infections, the panel said. The data also suggests that they are likely to shed more viruses and potentially infect more people than those who are not immunocompromised.

Early data from small studies on the effects of booster doses in immunocompromised patients showed no serious side effects from a third vaccination with an mRNA vaccine and symptoms beyond those identified after the first two-dose dose.

Several countries, including Israel, the Dominican Republic, France, the UK and Germany, have either already started or are considering giving booster doses of Covid-19 vaccines.

Immunocompromised patients receiving a third dose should continue to wear a mask and social distancing, the panel said.

Survey data from hesitant immunocompromised patients show that, according to a panel presentation by Dr. Kathleen Dooling of the CDC still has many worried about the side effects of the vaccines and the speed at which the vaccines have been developed, as well as the general suspicion about the vaccines.

Around 10% of immunocompromised patients say they will “definitely not” receive a vaccine, another 9% say they are “unsure” or “probably not” and 44% say they will “definitely” get a vaccine. Those who hesitate are usually younger, belong to an ethnic or racial minority, or are female.

Categories
Health

U.S. well being division mandates Covid vaccine pictures for its 25,000 workers

U.S. health department mandates Covid vaccine shots for its 25,000 employees

Xavier Becerra, the Health and Human Services (HHS) candidate, attends his Senate Finance Committee hearing on Capitol Hill in Washington on February 24, 2021.

Michael Reynolds | Swimming pool | Reuters

The Department of Health and Human Services is ordering Covid-19 vaccine syringes for the agency’s 25,000-plus employees, making it the latest government agency to require vaccinations in response to the global surge in the Delta variant.

The mandate announced Thursday by HHS Secretary Xavier Becerra covers the Indian Health Service, the National Institutes of Health, and the US Public Health Service Commissioned Corps – three agencies overseen by the department – and staff working with patients in medical or clinical research facilities of the federal government work together.

“Our ultimate goal is the health and safety of the American public, including our federal employees, and vaccines are the best tool we have to protect people from COVID-19, prevent the spread of the Delta variant, and save lives” Becerra said in a statement from HHS.

Members of the commanded corps must also be vaccinated against the virus if they are called to active duty as emergency services. The new mandate follows the agency’s existing religious and medical exemptions for vaccinations against influenza and other diseases.

The decision is made just days after the Pentagon issued a Covid vaccination mandate for all service members to be vaccinated by mid-September. The Department of Veterans Affairs became the first major federal agency to issue a Covid vaccination mandate for health workers last month.

President Joe Biden also announced mandatory vaccination for all federal employees on July 29, giving them the alternative of having weekly coronavirus tests instead of showing proof of vaccination. HHS did not state whether employees could choose to get tested for the coronavirus regularly instead of getting vaccinated.

Company executives are also increasingly exercising vaccine mandates. Companies including Google, Facebook, United Airlines and Tyson Foods are now demanding that some or all of their employees be vaccinated as the number of coronavirus cases in the US has risen recently.

Categories
Health

U.S. academics union says Covid case surge in youngsters led to again necessary photographs

U.S. teachers union says Covid case surge in kids led to back mandatory shots

A healthcare worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine to a student during a ‘Vax To School’ campaign event at a high school in the Staten Island borough of New York, U.S., on Tuesday, Aug. 10, 2021.

Jeenah Moon | Bloomberg | Getty Images

A recent surge of Covid cases in kids across the U.S. led the nation’s second-largest teachers union to back vaccine mandates for educators as schools prepare for in-person learning this fall, said Randi Weingarten, president of the American Federation of Teachers.

“This is what really scares me: in the last three weeks, we’ve gone from the number of kids testing positive from 20,000 to 40,000 to 72,000,” she said, citing data from July. The number of kids who tested positive for Covid during the week ended Aug. 5 was even higher at 93,824, according to the most recent data from the American Academy of Pediatrics.

Weingarten, who was speaking in an interview Wednesday with CNBC’s “Squawk Box,” said schools should give teachers time off to get the shots and allow for medical and religious exemptions for those who don’t want them.

“Kids under 12 can’t get vaccines, this delta virus is very transmissible, so we need to be in school for our kids, with our kids, but we need to keep everyone safe,” Weingarten said. “And that means vaccines are the single most important way to do it, and the second way to do it is masks.”

Approximately 90% of teachers are already vaccinated, Weingarten said during the interview, citing White House data. But with many children still ineligible for vaccination, Weingarten stopped short of advocating for an immunization requirement for students under 12.

As the delta variant surges, states have begun enhancing their Covid mitigation protocols to prevent the virus from spreading among faculty and students. On Aug. 4, Illinois Gov. JB Pritzker introduced a mask mandate for all state students regardless of their vaccination status.

New Jersey also issued a mask mandate for all students and staff on Friday, and Louisiana’s mask mandate for public indoor settings includes students from kindergarten through college.

Becky Pringle, president of the largest U.S. teachers’ union, the National Education Association, told the New York Times last week that any vaccine mandate should be negotiated at the local level.

Reuters contributed to this report.